1
A Phase 1B Dose-escalation and Phase 2a Study of Carotuximab (TRC105) in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma
Condition(s):Advanced Soft Tissue SarcomaLast Updated:May 20, 2020Completed
Advanced Soft-tissue Sarcoma: 652 Clinical Trials, Page 1 of 66
Hide Studies Not Open or Pending
2
Study of NY-ESO-1 TCR-T in Advanced Soft Tissue Sarcoma
Condition(s):Advanced Soft-tissue SarcomaLast Updated:November 22, 2022Recruiting
3
Surufatinib and Envafolimab as Second or More-line Therapy in Advanced Soft Tissue Sarcoma Patients
Condition(s):Efficacy and Safety of Surufatinib Combined With Envafolimab as Second or More-line Therapy in Advanced Soft Tissue Sarcoma PatientsLast Updated:February 10, 2023Not yet recruiting
4
Olaratumab Plus Trabectedin in Advanced Soft-tissue Sarcoma Patients Soft-tissue Sarcoma Patients
Condition(s):Sarcoma, Soft TissueLast Updated:March 27, 2023Active, not recruiting
5
Phase I/II of LB-100 Plus Doxorubicin vs. Doxorubicin Alone in First Line of Advanced Soft Tissue Sarcomas
Condition(s):Advanced Soft-tissue SarcomaLast Updated:July 10, 2023Recruiting
6
Dose-Escalation Study of TH-302 in Combination With Doxorubicin to Treat Patients With Advanced Soft Tissue Sarcoma
Condition(s):Soft Tissue SarcomaLast Updated:October 26, 2017Completed
7
A 3 Arm Randomized Study on Health-related QoL of Elderly Patients With Advanced Soft Tissue Sarcoma
Condition(s):Advanced Soft-tissue SarcomaLast Updated:July 5, 2022Recruiting
8
SAINT:Trabectedin, Ipilimumab and Nivolumab as First Line Treatment for Advanced Soft Tissue Sarcoma
Condition(s):Advanced Soft Tissue Sarcoma; Metastatic Soft Tissue SarcomaLast Updated:May 18, 2023Recruiting
9
Gemcitabine Plus Rapamycin Versus Gemcitabine to Treat Advanced Soft Tissue Sarcoma
Condition(s):Advanced Soft Tissue SarcomaLast Updated:October 27, 2015Completed
10
Anlotinib Maintenance Treatment for Advanced Soft Tissue Sarcoma
Condition(s):Soft Tissue SarcomaLast Updated:August 1, 2023Recruiting